Concepedia

Publication | Open Access

Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy

DOIFull Paper Access

32

Citations

17

References

2020

Year

Hirofumi Komaki, Yoshihiro Maegaki, Tsuyoshi Matsumura, Kazuhiro Shiraishi, Hiroyuki Awano, Akinori Nakamura, Satoru Kinoshita, Katsuhisa Ogata, Keiko Ishigaki, Shinji Saitoh,
Annals of Clinical and Translational Neurology

Abstract

The HPGDS inhibitor TAS-205 showed a favorable safety profile in DMD patients. Further research is required to examine the effectiveness of TAS-205 in a larger trial.

References

YearCitations

Page 1